Gov. JB Pritzker signed SB 667 into law, capping out of pocket insulin costs at $100 for a 30-day supply. The new law is an important step forward in lowering healthcare costs for working families making Illinois a leader in ensuring healthcare is a right, not a privilege. The 1.3 million Illinoisans who rely on insulin will no longer face soaring prescription drug prices that force them to make tough decisions. Diabetes affects approximately 1,300,000 adults in Illinois. All people with Type 1 diabetes and some with Type 2 diabetes need insulin, but regular price hikes make insulin difficult to afford for the uninsured and those whose coverage requires significant cost sharing. Many patients either forego insulin or they ration their prescribed insulin dose to stretch it until they can afford the next prescription. One in four Type 1 diabetics have reported insulin underuse due to the high cost of insulin. The majority of the law’s provisions go into effect in January 2021; provisions requiring an insulin pricing report take effect immediately.